Global Cosmetic Grade Nicotinamide Mononucleotide Market Growth 2025-2031
Description
The global Cosmetic Grade Nicotinamide Mononucleotide market size is predicted to grow from US$ 264 million in 2025 to US$ 301 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
United States market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cosmetic Grade Nicotinamide Mononucleotide players cover GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cosmetic Grade Nicotinamide Mononucleotide Industry Forecast” looks at past sales and reviews total world Cosmetic Grade Nicotinamide Mononucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Cosmetic Grade Nicotinamide Mononucleotide sales for 2025 through 2031. With Cosmetic Grade Nicotinamide Mononucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cosmetic Grade Nicotinamide Mononucleotide industry.
This Insight Report provides a comprehensive analysis of the global Cosmetic Grade Nicotinamide Mononucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cosmetic Grade Nicotinamide Mononucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cosmetic Grade Nicotinamide Mononucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cosmetic Grade Nicotinamide Mononucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cosmetic Grade Nicotinamide Mononucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Grade Nicotinamide Mononucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Concentration≥98%
Concentration＜98%
Segmentation by Application:
Skin Care Products
Cosmetic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cosmetic Grade Nicotinamide Mononucleotide market?
What factors are driving Cosmetic Grade Nicotinamide Mononucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cosmetic Grade Nicotinamide Mononucleotide market opportunities vary by end market size?
How does Cosmetic Grade Nicotinamide Mononucleotide break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
United States market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Cosmetic Grade Nicotinamide Mononucleotide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Cosmetic Grade Nicotinamide Mononucleotide players cover GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Cosmetic Grade Nicotinamide Mononucleotide Industry Forecast” looks at past sales and reviews total world Cosmetic Grade Nicotinamide Mononucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Cosmetic Grade Nicotinamide Mononucleotide sales for 2025 through 2031. With Cosmetic Grade Nicotinamide Mononucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cosmetic Grade Nicotinamide Mononucleotide industry.
This Insight Report provides a comprehensive analysis of the global Cosmetic Grade Nicotinamide Mononucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cosmetic Grade Nicotinamide Mononucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cosmetic Grade Nicotinamide Mononucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cosmetic Grade Nicotinamide Mononucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cosmetic Grade Nicotinamide Mononucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Grade Nicotinamide Mononucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Concentration≥98%
Concentration＜98%
Segmentation by Application:
Skin Care Products
Cosmetic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GeneHarbor
Herbalmax
Shinkowa
EffePharm
Mirailab Bioscience
Bangtai Bio
Jindawei
Hongboyuan Life Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cosmetic Grade Nicotinamide Mononucleotide market?
What factors are driving Cosmetic Grade Nicotinamide Mononucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cosmetic Grade Nicotinamide Mononucleotide market opportunities vary by end market size?
How does Cosmetic Grade Nicotinamide Mononucleotide break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Cosmetic Grade Nicotinamide Mononucleotide by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Cosmetic Grade Nicotinamide Mononucleotide by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
